FOR AUTHORS
Vol. 18 No. s1 (2026): 62° Congresso Nazionale ADOI, Firenze, 17-19 settembre 2026
Published:
24 September 2026
62° Congresso Nazionale ADOI, Firenze, 17-19 settembre 2026
-
01 | THE SKIN: A COGNITIVE AND AFFECTIVE STORY G. Caresana | Dermatologic Surgery, Casa di Cura Piacenza, Italy
0PDF: 0 -
02 | LINE-FIELD CONFOCAL OPTICAL COHERENCE TOMOGRAPHY CORRELATES OF DERMOSCOPIC GLOBULES G. Cortonesi, V. Cioppa, L. Tognetti, P. Rubegni, E. Cinotti | UOC Dermatologia, AOU Senese, Siena University, Italy
0PDF: 0 -
03 | FROM COMPOUNDING PHARMACY TO PRECISION MEDICINE: THE ROLE OF TAILOR-MADE FORMULATIONS IN AESTHETIC DERMATOLOGY G. Malara | Università degli Studi di Enna "kore", Italy
0PDF: 0 -
04 | NODULAR LYMPHANGITIS CAUSED BY MYCOBACTERIUM CHELONAE G. Colombo, E. Banchetti, G. Perazzolli | Dermatology Unit, Ospedale Maggiore, Verona, Italy
0PDF: 0 -
06 | PERIOCULAR “ULCUS RODENS-LIKE” SQUAMOUS CELL CARCINOMA TREATED WITH CEMIPLIMAB: A CASE REPORT A. Zordan1, M. Fino1, N. Di Meo1, I. Zalaudek1, C. Defferrari2, S. Sola3, C. Massone4 | 1Department of Dermatology and Venereology, University of Trieste, Maggiore Hospital, Trieste, Italy; 2Department of Oncology, Galliera Hospital, Genoa, Italy; 3Department of Pathology, Galliera Hospital, Genoa, Italy; 4Department of Dermatology, Galliera Hospital, Genoa, Italy
0PDF: 0 -
07 | CHILBLAIN LUPUS: A RARE FORM OF CUTANEOUS LUPUS ERYTHEMATOSUS - A CASE REPORT G. Perazzolli1, E. Banchetti1, E. Melis1, A. Carletto2, G. Girolomoni1, P. Gisondi1 | 1Section of Dermatology and Venereology, Department of Medicine, University of Verona, Italy; 2Section of Rheumatology, Department of Medicine, University of Verona, Italy
0PDF: 0 -
08 | FINAL DESTINATION: THE PURSE-STRING CLOSURE M. Crivellari, M. Venturini, P. Monari | Dermatology Department, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
0PDF: 0 -
09 | NANOFAT 20: EXPERIMENTAL PHASES AND CLINICAL APPLICATIONS G. Mannino1, G.A.G. Lombardo1, S. Tamburino2, I. R. Romano3, R. Giuffrida3, D. Lo Furno3 | 1Department of Medicine and Surgery, School of Medicine and Surgery, University of Enna “Kore”, Italy; 2Chi.Pla Chirurgia Plastica private office, Catania, Italy; 3Department of Biomedical and Biotechnological Sciences, University of Catania, Italy
0PDF: 0 -
10 | LEBRIKIZUMAB PROVIDES CLINICALLY MEANINGFUL RESPONSE IN FACE AND HANDS IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ADHOPE 1 STUDY L. Stingeni1, C. Vestergaard2, J. Seneschal3|4, S. Weidinger5, A. Wollenberg6|7|8, A. Irvine9, H. Agell10, J. Valls Bancells10, V. Sapena10, D. Thaçi7 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Dermatology, University of Bordeaux, Bordeaux, France; 4Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, France; 5Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany; 6University Medical Center of Augsburg, Augsburg, Germany; 7Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 8Department of Dermatology and Allergology, LMU Hospital, Munich, Germany; 9Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 10Almirall S.A., Barcelona, Spain
0PDF: 0 -
11 | EFFICACY AND SAFETY OF LEBRIKIZUMAB IS MAINTAINED UP TO 4 YEARS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: FIRST YEAR OF ADLONG LONG-TERM EXTENSION TRIAL L. Stingeni1, S. Weidinger2, A. Irvine3, D. Thaçi4, J. Szepietowski5, T. Biedermann6, H. Agell7, Y. Mihaylov7, B. Kostov7, R. Coll7, W. Romero8, K. Reich9 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; 3Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 4Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 5Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland; 6Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany; 7Almirall S.A., Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
0PDF: 0 -
12 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, US; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, US; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CA; 5Chang Gung University College of Medicine, Taoyuan, TW; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JP; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, DE; 8Department of Dermatology and Population Health Sciences, King’s College London, London, UK; 9Ada West Dermatology, St Luke's Children's Hospital, Idaho, US; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AU; 11Eli Lilly and Company, Indianapolis, Indiana,US; 12Almirall R&D, S.A., Barcelona, ES; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, US
0PDF: 0 -
13 | SOLAR LENTIGO TREATED WITH A 2940 NM ERBIUM LASER: ABLATION AND INSTRUMENTAL ASSESSMENT G.I. Luppino | Dermatological Clinic, University of Catania, Italy
0PDF: 0 -
14 | CUTANEOUS LEISHMANIASIS MIMICKING B-CELL PSEUDOLYMPHOMA: A DIAGNOSTIC CHALLENGE IN AN ENDEMIC MEDITERRANEAN AREA M. Fino1, A. Zordan1, N. Di Meo1, I. Zalaudek1, S. Sola2, C. Massone3 | 1Department of Dermatology and Venereology, University of Trieste, Maggiore Hospital, Trieste, Italy; 2Department of Pathology, Galliera Hospital, Genoa, Italy; 3Department of Dermatology, Galliera Hospital, Genoa, Italy
0PDF: 0 -
17 | THE DIAGNOSTIC COMPLEXITY OF PERSISTENT ERYTHEMA MULTIFORME: A REPORT OF TWO CLINICAL CASES S. Visinoni, V. Rubino, S. Colabrese, L. Cerchiai, M. E. Baffa, C. Pipitò, R. Maglie, E. Antiga | Dermatology, University of Florence, Italy
0PDF: 0 -
20 | WHERE THE SUN DOESN'T SHINE, UV FLUORESCENCE DOES: DIAGNOSTIC AND THERAPEUTIC INSIGHTS OF UV-INDUCED FLUORESCENCE DERMOSCOPY IN SCROTAL POROKERATOSIS Z. Fratton1|2, M. Milani3, D. Strippoli4, A. Ponziani4, F. Fantini4, M. Andreassi4 | 1Department of Medicine, Institute of Dermatology, University of Udine, Italy; 2Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy; 3Department of Pathology, ASST Lecco, Alessandro Manzoni Hospital, Lecco, Italy; 4Dermatology Unit, ASST Lecco, Alessandro Manzoni Hospital, Lecco, Italy
0PDF: 0 -
21 | A MIMIC DERMATOSIS OF THE LEFT EYELID A. Motolese, A. Conti | Dermatology, Infermi Hospital, AUSL Romagna, Rimini, Italy
0PDF: 0 -
22 | COMPLEX CUTANEOUS LEISHMANIASIS: A REPORT OF TWO CASES FROM THE DERMATOLOGY UNIT OF THE UNIVERSITY OF BOLOGNA, SANT’ORSOLA-MALPIGHI HOSPITAL M. Ferrante1|2, M. La Placa 1|2, V. Gaspari1 | 1 Dermatology Unit, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy; 2 Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Italy
0PDF: 0 -
23 | CURRENT CHALLENGES IN MODERATE ATOPIC DERMATITIS: AN ITALIAN DELPHI CONSENSUS I. Marzona1, A. Costanzo2, A. Campanati3, M. Esposito4, S. M. Ferrucci5, G. Girolomoni6, C. Patruno7, E. Pezzolo8, S. Ribero9, M. Rossi10, L. Stingeni11, L. Politi1, M. Napolitano12 | 1Helaglobe Srl; 2Dermatology Unit, IRCCS Humanitas Research Hospital Dermatology, Italy; 3Dermatological Clinic, Università Politecnica delle Marche, Italy; 4Biotechnological and Clinical Sciences University of L’Aquila, Italy; 5IRCCS Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Italy; 6Section of Dermatology, University of Verona, Italy; 7Medicine and Health Sciences, Molise University, Italy; 8Department of Dermatology, San Bortolo Hospital, Italy; 9Dermatology Clinic, University of Turin, Italy; 10Dermatology Unit, University of Brescia, Italy; 11Dermatology Section, University of Perugia, Italy; 12Section of Dermatology, University of Naples, Italy
0PDF: 0 -
24 | IXEKIZUMAB WITH OR WITHOUT TIRZEPATIDE IN ADULTS WITH PSORIASIS AND OVERWEIGHT OR OBESITY: THE TOGETHER-PSO PHASE 3B RANDOMIZED CLINICAL TRIAL E. Filippi1, M. Lebwohl2, A. Blauvelt3, C. Kartman4, C. Leatherwood4, K. Gordon5, N. Sattar6, L. Puig7, J. Merola8, K. Siu4, R. Wang4, L. Sun4, A. Leung9, N. Somani4, M. Rueda4, A. Cardoso4, M. Genovese4, A. Armstrong10, B. Strober11 | 1Eli Lilly Italy S.p.A, Sesto Fiorentino, Italy; 2Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3Blauvelt Consulting, LLC, Annapolis, MD, USA; 4Eli Lilly and Company, Indianapolis, IN, USA; 5Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA; 6School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; 7Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain; 8Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; 9Syneos Health, Morrisville, NC, USA; 10Division of Dermatology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA; 11Department of Dermatology, Yale University School of Medicine, New Haven, CT, Central Connecticut Dermatology Research, Cromwell, CT, USA
0PDF: 0 -
25 | EARLY AND MAINTAINED TREAT-TO-TARGET RESPONSE WITH IXEKIZUMAB UP TO 5 YEARS IN MODERATE-TO-SEVERE PSORIASIS: A POST-HOC ANALYSIS OF UNCOVER-3 E. Filippi1, A. Armstrong2, J. F. Merola3, M. Megna4, X. Man5, M. Honma6, J-M. Carrascosa7, R. Chughtai7, K. Fotiou8, S. Sabatino8, M. Ngantcha8, A. Pinter9 | 1Eli Lilly Italia S.p.A, Florence, Italy; 2University of California, Los Angeles, CA, USA; 3University of Texas Southwestern Medical Center, Dallas, TX, USA; 4University of Naples Federico II, Naples, Italy; 5Zhejiang University, Hangzhou, China; 6Asahikawa Medical University, Asahikawa, Japan; 7Hospital Germans Trias, Universitat Autònoma de Barcelona, Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9University Hospital Frankfurt, Frankfurt, Germany
0PDF: 0 -
26 | CONCOMITANT THERAPY WITH IXEKIZUMAB PLUS TIRZEPATIDE IN ADULTS WITH PSORIATIC ARTHRITIS AND OVERWEIGHT OR OBESITY DEMONSTRATED SUPERIOR DISEASE CONTROL COMPARED TO IXEKIZUMAB ALONE: RESULTS FROM THE PH3B TOGETHER-PSA TRIAL E. Filippi1, J. F. Merola2, P. Mease3, A. Kivitz4, N. Sattar5, L. C. Coates6, C. E. Kartman7, P. Fischer7, L. Sun7, A. Cardoso7, M. C. Genovese7, A. Ogdie8 | 1Eli Lilly Italia S.p.A, Florence, Italy; 2Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; 3Providence Swedish Medical Center, Seattle, WA, USA; 4Altoona Center for Clinical Research, Duncansville, PA, USA; 5School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; 6Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; 7Eli Lilly and Company, Indianapolis, IN, USA; 8Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
0PDF: 0 -
27 | PRIMUM NON NOCERE P. Monari, I. Cattaneo | Dermatology Unit, Spedali Civili di Brescia, Italy
0PDF: 0 -
28 | COMPLICATIONS IN DERMOSURGERY: COMPARISON BETWEEN LITERATURE AND REAL-LIFE EXPERIENCE IN BRESCIA P. Monari, I. Cattaneo | Dermatology Unit, Spedali Civili di Brescia, Italy
0PDF: 0 -
29 | INNOVATIVE THERAPEUTIC STRATEGIES IN GENODERMATOSIS: AN ITALIAN MULTICENTRE STUDY F. Pavan1, F. Cassalia2, S. Giordano3, A. Gelmetti4, L. Ventura5, F. Caroppo2, A. Bassi6, F. Martorana7, R. Balestri8, A. Guglielmo9, F. Ambrogio10, A. Bonvicino3, I. Neri4, P. Quaglino3, A. Belloni Fortina11 | 1Pediatrics Unit, Department of Women’s and Child’s Health (SDB), University of Padua, Italy; 2Dermatology Unit, Department of Medicine (DIMED), University of Padua, Italy; 3Department of Medical Sciences, Section of Dermatology, University of Turin, Italy; 4Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Italy; 5Department of Statistical Science, University of Padua, Italy; 6Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; 7Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II; 8Division of Dermatology, Outpatient Consultation for Rare Diseases, APSS, Trento, Italy; 9Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy; 10Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, Italy; 11Pediatric Dermatology Department of Women’s and Child’s Health (SDB), University of Padua, Italy
0PDF: 0 -
30 | ATOPIC DERMATITIS AND ULCERATIVE COLITIS: A CASE REPORT ON THE MANAGEMENT OF OVERLAPPING COMORBIDITIES S. Senatore1, C. Cardinali1, A. Pieraccini2, F. Taviti1 | 1SOC Dermatologia Pistoia-Prato, USL Toscana Centro, Italy; 2SOC Gastroenterologia ed Endoscopia, USL Toscana Centro, Italy
0PDF: 0 -
31 | DRUG ECONOMIC ANALYSIS OF THE DOSE SPACING OF BIOLOGICAL DRUGS IN ATOPIC DERMATITIS AND PSORIASIS A. Filoni1, L. Pietroleonardo1, P. Stasi2, M. Spagnolo2, F. Scicchitano2, S. Pelle3, M. Congedo1 | 1UOSVD Dermatology and Allergology, Hospital Vito Fazzi, Lecce, Italy; 2Servizio Farmaceutico Distrettuale. Asl Lecce, Italy; 3Dermatology Outpatient Unit, Asl Lecce, Italy
0PDF: 0 -
32 | BEYOND AREA REDUCTION: PULSED DYE LASER TREATMENT OF BASAL CELL CARCINOMA IN A PRELIMINARY REAL-WORLD COHORT G. Frattin1|2, A. Bolzon1|2, E. Pezzolo1, L. Germi1, L. Gnesotto1, A. Corrà1, G. Mioso1, Z. Fratton1, L. Schiesari1 | 1UOC Dermatologia, Ospedale San Bortolo, Vicenza, Italy; 2Università degli Studi di Padova, Clinica Dermatologica, Italy
0PDF: 0 -
33 | GENITAL POROKERATOSIS CONFIRMED BY HISTOPATHOLOGY AND REFLECTANCE CONFOCAL MICROSCOPY: A RARE CASE REPORT G. Frattin1|2, A. Bolzon1|2, E. Pezzolo1, L. Germi1, L. Gnesotto1, A. Corrà1, G. Mioso1, Z. Fratton1, L. Schiesari1 | 1UOC Dermatologia, Ospedale San Bortolo, Vicenza, Italy; 2Università degli Studi di Padova, Clinica Dermatologica, Italy
0PDF: 0 -
34 | SMART SURGERY FOR SPECIFIC ANATOMICAL DISTRICTS M. Donini | U.O.C. Dermatologia, Ospedale Civile Venezia, Italy
0PDF: 0 -
35 | DIAGNOSTIC PITFALLS IN CUTANEOUS ULCERS: ARE THEY JUST ULCERS? V. Schirripa1, A. Schirripa2 | 1Private Practice Dermatologist, Former Director of the Dermatology Unit, Hospital of Locri, (RC), Italy; 2Specialist in Hygiene and Preventive Medicine, Italy
0PDF: 0 -
36 | MORBIHAN DISEASE IN A MAURITIAN PATIENT: A CASE REPORT AND REVIEW OF THE ASIAN LITERATURE G. Hoxhallari1|4, R. Bortone2, A. R. Meduri2, B. Tirone2, F. Drago3, C. Foti2, D. Bonamonte2, M. Bellino2, G. Ciccarese1 | 1Unit of Dermatology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy; 2Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari “Aldo Moro”, Bari, Italy; 3Casa di Cura Villa Montallegro, Genova, Italy; 4Department of Dermatology and Venereology, Mother Teresa University Hospital Center, Tirana, Albania
0PDF: 0 -
38 | A GIFT FROM ECUADOR: IMPORTED CUTANEOUS MYIASIS CAUSED BY DERMATOBIA HOMINIS D. Tesauri1, F. Di Cioccio1, T. Galeotti1, L. Bianchi1, K. Hansel1, L. Stingeni1, F. Veronesi2, I. Moretta2 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Veterinary Medicine, University of Perugia, Italy
0PDF: 0 -
40 | BEYOND THE USUAL CAT: TRICHOPHYTON BENHAMIAE KERION CELSI IN A CHILD WITH CHINCHILLA-ASSOCIATED HOUSEHOLD OUTBREAK T. Galeotti1, D. Tesauri1, P. Caposciutti1, L. Bianchi1, S. Crotti2, D. Cruciani2, K. Hansel1, L. Stingeni1 | 1Dermatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 2Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati", Perugia, Italy
0PDF: 0 -
41 | METABOLIC DYSREGULATION AND IMMUNE ACTIVATION IN VITILIGO: UNVEILING THE MITOCHONDRIAL AND INFLAMMATORY IMPRINT OF DISEASE PATHOGENESIS S. Caputo1, A. Marini1, S. Scano1, F. Papaccio1, R. Marrapodi1, P. Iacovelli2, A. Presaghi3, E. Migliano3, C. Cota4, A. Filoni5, M. Picardo6, B. Bellei1 | 1Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Rome, Italy; 2Clinical Dermatology, Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy; 3Department of Plastic and Regenerative Surgery, San Gallicano Dermatological Institute, IRCCS, Rome, Italy; 4Genetic Research, Molecular Biology and Dermatopathology Unit, San Gallicano Dermatological Institute, Rome, Italy; 5UOSVD Dermatology and Allergology, Hospital Vito Fazzi, Lecce, Italy; 6Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy
0PDF: 0 -
43 | LONGSTANDING GENERALIZED EXTRAGENITAL LICHEN SCLEROSUS WITH GENITAL INVOLVEMENT UNMASKED BY ACUTE INFLAMMATORY DERMATOSIS V. Corti1, L. Sanna1, A. Magnatta1, R. Daher1, S. Landini1, A. Verdelli2, M. Caproni2 | 1Sezione di Dermatologia, Dipartimento di Scienze della salute, Università di Firenze, Italy; 2S.O.S. Immunopatologia cutanea e malattie rare dermatologiche, P.O. Piero Palagi, Azienda USL Toscana Centro, Dipartimento di Scienze della Salute Università degli Studi di Firenze, Italy
0PDF: 0 -
44 | EXTENSIVE ULCERATIVE-BULLOUS LESIONS IN A PATIENT WITH GRANULOMATOSIS WITH POLYANGIITIS: A DIAGNOSTIC CHALLENGE F. Fazzari1, G. Cecchi1, C. Cardinali2, D. Bonciani2, F. Taviti2 | 1Department of Health Sciences, Section of Dermatology, University of Florence, Italy; 2SOC, Pistoia-Prato Hospital, USL Toscana Centro, Pistoia, Italy
0PDF: 0 -
45 | CLINICAL, DERMOSCOPIC AND HISTOPATHOLOGICAL FEATURES OF A RARE CASE OF ERUPTIVE ANNULAR LICHEN PLANUS V. Filastro1, M. Ferrante2|3, L. Gini2|3, G. Martelli2|3, M. La Placa2|3, I. Neri3 | 1Dermatology Unit, Health Science Department, Magna Graecia University, Catanzaro, Italy; 2Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Italy; 3Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy
0PDF: 0 -
46 | IS AJCC STAGE IIA MELANOMA A HOMOGENEOUS DISEASE? A 23-YEAR SINGLE-CENTER EXPERIENCE C. Cescatti1, C. Trevisiol2, P. Del Fiore2, G. Madeo3, N. Romagnolo4, F. Cassalia2, A. Acciardi2, S. Mocellin2|3, M. Alaibac4 | 1Department of Medicine (DIMED), School of Medicine, University of Padova, Italy; 2Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Italy; 3Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Italy; 4Dermatology Unit, Department of Medicine, University of Padova, Italy
0PDF: 0 -
47 | RECURRENCE DEFINES PROGNOSIS IN THICK MELANOMA: A LONG-TERM SINGLE-CENTER EXPERIENCE S. Apa1, P. Del Fiore2, C. Trevisiol2, G. Madeo3, N. Romagnolo4, F. Cassalia2, A. Acciardi2, S. Mocellin2|3, M. Alaibac4 | 1Department of Medicine (DIMED), School of Medicine, University of Padova, Italy; 2Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Italy; 3Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Italy; 4Dermatology Unit, Department of Medicine, University of Padova, Italy
0PDF: 0 -
51 | TRICHOSCOPIC CLUES TO ALOPECIA NEOPLASTICA SECONDARY TO BREAST CARCINOMA: A CASE REPORT A. Sechi1, P. Ferrero1|2, L. Valtellini1|2, G. Perego1|2, A. Marzano1|2 | 1Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 2Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
0PDF: 0 -
52 | ADULT LANGERHANS CELL HISTIOCYTOSIS: A DERMATOLOGICAL DIAGNOSTIC CHALLENGE UNVEILING MULTISYSTEM DISEASE M. Donati1, A. Corrà2, A. Verdelli3, N. Pimpinelli3, C. Longo1, M. Caproni3 | 1Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy; 2Dermatology Unit, Ospedale San Bartolo, Vicenza, Italy; 3Section of Dermatology, Department of Health Sciences, University of Florence, Italy
0PDF: 0 -
53 | MAMMARY PAGET DISEASE WITH OCCULT DCIS: A RARE MALE CASE M. Fino1, C. Brunello1, N. Di Meo1, I. Zalaudek1, S. Sola2, C. Massone3 | 1Department of Dermatology and Venereology, University of Trieste, Maggiore Hospital, Trieste, Italy; 2Department of Pathology, Galliera Hospital, Genoa, Italy; 3Department of Dermatology, Galliera Hospital, Genoa, Italy
0PDF: 0 -
55 | PAEDIATRIC FOLLICULAR MUCINOSIS WITHOUT PROGRESSION TO MYCOSIS FUNGOIDES: A LONG-TERM CLINICOPATHOLOGIC STUDY A. Di Guardo1, L. Ambrosio1|2, M. Testa1, D. Didona1, F. Moro1|2, A. Rallo1, G. Di Lella1, L. Colonna1, S. Pallotta1, A. Panebianco1, L. Fania1|3 | 1IDI-IRCCS, Dermatological Research Hospital, Rome, Italy; 2UOC of Dermatology, Department of Medical and Cardiovascular Sciences, “Sapienza” University of Rome, Italy; 3Department of Life Science, Health, and Health Professions, Link University of Rome, Italy
0PDF: 0 -
56 | FIRST-LINE EXTRACORPOREAL PHOTOPHERESIS PLUS INTERFERON-Α IN SÉZARY SYNDROME: REAL-WORLD SURVIVAL AND EXPLORATORY BLOOD BIOMARKERS A. Di Guardo1, M.P. Accetturi1, C. Cristofoletti1, A. Frezzolini1, E. Scala1, L. Fania1|2, A. Monopoli1, M.G. Narducci1 | 1IDI-IRCCS, Dermatological Research Hospital, Italy; 2Department of Life Science, Health, and Health Professions, Link University of Rome, Italy
0PDF: 0 -
57 | GENERALIZED PLANE XANTHOMA AND NECROBIOTIC XANTOGRANULOMA HERALDING PROGRESSION FROM MGUS TO MULTIPLE MYELOMA: COMPLETE CUTANEOUS RESOLUTION AFTER MYELOMA-DIRECTED THERAPY M. Di Prete1, V. Lora2, C. Cota1 | 1Dermatopathology Research Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy; 2Clinical Dermatology, San Gallicano Dermatological Institute IRCCS, Rome, Italy
0PDF: 0 -
58 | EARLY COCAINE-INDUCED PERIORIFICIAL DERMATOMUCOSITIS: A CASE SERIES EXPANDING THE CLINICOPATHOLOGICAL SPECTRUM BEYOND MIDLINE DESTRUCTIVE LESIONS V. Lora1, M. Di Prete2, C. Cota2 | 1Clinical Dermatology, San Gallicano Dermatological Institute IRCCS, Rome, Italy; 2Dermatopathology Research Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy
0PDF: 0 -
59 | EXPLORATORY THERAPEUTIC APPROACH IN DERCUM’S DISEASE: IMMUNOMODULATORS AND GLP-1 RECEPTOR AGONISTS A. Magnatta1, M. Caproni2 | 1Department of Health Sciences, Section of Dermatology, University of Florence, Italy; 2Department of Health Sciences, Rare Disease Dermatological Unit, Section of Dermatology, University of Florence, P. Palagi Hospital, Florence, Italy
0PDF: 0 -
60 | DERMATOMYOSITIS AS A CUTANEOUS SENTINEL OF OCCULT INTRAMUCOSAL RECTAL ADENOCARCINOMA: THE CRITICAL ROLE OF DERMATOLOGIC RECOGNITION AND MALIGNANCY SCREENING L. Sanna, M. Caproni | Dermatology, University of Florence, Italy
0PDF: 0 -
61 | SUNITINIB-INDUCED FOLLICULAR OCCLUSION DISORDER OF THE FACE: A CASE REPORT Z. Fratton1|2, A. Bolzon2|3, A. Corrà2, G. Frattin2|3, L. Germi2, L. Gnesotto2, D. Lai2, G. Mioso2, E. Pezzolo2, L. Schiesari2 | 1Department of Medicine, Institute of Dermatology, University of Udine, Italy; 2Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy; 3Unit of Dermatology, Department of Medicine, University of Padova, Italy
0PDF: 0 -
63 | DIFFUSE ERYTHRODERMA IN A COMPLEX GERIATRIC PATIENT: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE M.R. Nasca, M. Celsa, G. Micali | Clinica Dermatologica, Università di Catania, Italy
0PDF: 0 -
64 | DERMATOLOGY, RHEUMATOLOGY, AND SKIN ULCERS: CASES OF PRACTICAL INTEREST M. Nicolini | Ast ANCONA-Regione Marche, UOC Dermatologia Ospedale Carlo Urbani Jesi (AN), Italy
0PDF: 0 -
65 | RETRONICHIA UP TO DATE A. Podo Brunetti, G. Cannata | Dermatologia Clinica, Università Vita-Salute San Raffaele, Milan, Italy
0PDF: 0 -
67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; 5Chang Gung University College of Medicine, Taoyuan, Taiwan; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; 8Department of Dermatology and Population Health Sciences, King’s College London, UK; 9Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; 11Eli Lilly and Company, Indianapolis, Indiana, USA; 12Almirall R&D, S.A., Barcelona, Spain; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
0PDF: 0 -
68 | FULMINANT SJS/TEN-LIKE PEMPHIGUS VULGARIS WITH HIGH ANTI-DSG1 TITERS AND CMV REACTIVATION: AN IMMUNOLOGICAL CHALLENGE R. Daher2, A. Verdelli1, L. Sanna2, V. Corti2, A. Magnatta2, S. Landini2, M. Donati3, I. Bonanni1, A. Corrà4, V. Ruffo Di Calabria5, E. Mariotti6, C. Della Bella7, L. Giovannoni8, M. D'Elios7, A. Moggi Pignone9, M. Caproni1 | (1)Rare Dermatological Diseases Unit, Department of Health Sciences, University of Florence, Florence, Italy; (2)Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy; (3)Dermatology Department, University of Modena and Reggio Emilia, Modena, Italy; (4)Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy; (5)SSD Dermatologia, Cardinal Massaia Hospital, Asti, Italy; (6)Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; (7)Department of Molecular and Developmental Medicine, University of Siena, Italy; (8)UOC Ricerca e Sviluppo Clinical Practice, AOU Careggi, Florence, Italy; (9)Department of Experimental and Clinical Medicine, Division of Internal Medicine, University of Florence, Italy
0PDF: 0
